Reduced bone mineral density after surgical treatment for obesity

International Journal of Obesity

Volumn 23, Issue 4, 1999, Pages 361-365

  Bano, G ^a   Rodin, D A ^a   Pazianas, M ^a   Nussey, S S ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Jejunoileal bypass; Osteoporosis; Pancreaticobiliary bypass

Indexed keywords

25 HYDROXYVITAMIN D; ALBUMIN; ALKALINE PHOSPHATASE; CALCIUM; CREATININE; ESTROGEN; GONADOTROPIN; MAGNESIUM; PHOSPHATE; SEX HORMONE; SOMATOMEDIN; TESTOSTERONE; THYROXINE; ZINC;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; BONE DENSITY; BONE MINERAL; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DUAL ENERGY X RAY ABSORPTIOMETRY; ENZYME ACTIVITY; FEMALE; FEMUR NECK; HUMAN; ILIAC CREST; JEJUNOILEAL BYPASS; LUMBAR SPINAL CORD; MALE; OBESITY; OSTEOPOROSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; QUESTIONNAIRE; STEROID BLOOD LEVEL; THYROXINE BLOOD LEVEL; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

ANIMALIA;

EID: 0032940982     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0800827     Document Type: Article

References (32)

1. 1 Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995; 108: 417-422.
2. 2 Valdimasson T, Lofman O, Toss G, Sjtorm M. Reversal of osteopenia with diet in adult coeliac disease. Gut 1996; 38: 322-327.
3. 3 Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, Reid EM, Rhodes J. Osteoporosis in patients with inflammatory bowel disease. Gut 1987; 28: 410-415.
4. 4 Croucher PI, Vedi S, Motley RJ, Garrahan NJ, Staton MR, Compston JE Reduced bone formation in patients with osteoporosis associated with inflammatory bowel disease. Osteopor Int 1993; 3: 236-241.
5. 5 Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal tabecular bone loss in patients with inflammatory bowel disease. Gut 1988; 29: 1332-1336.
6. 6 Clements D, Motlet RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, Compston JE. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992; 27: 1055-1060.
7. 7 Joffe SN. Surgical management of morbid obesity. Gut 1981; 22: 242-254.
8. 8 Dean P, Joshi S, Kaminski DL. Jejunoileal bypass: can the mistake be corrected? Gastroenterology 1990; 98: 1710-1719.
9. 9 Dean P, Joshi S, Kaminski DL. Long term outcome of reversal of small intestinal bypass operations. Am J Surg 1990; 159: 118-123.
10. 10 Hocking MP, Duerson MC, O'Leary JP, Woodward ER. Jejunoileal bypass for morbid obesity: late follow up on 100 cases. New Engl J Med 1983; 308: 995-999.
11. 11 McFarland RJ, Gazet JC, Pilkington TRE. A 13 year review of jejunoileal bypass. Br J Surg 1985; 72: 81-87.
12. 12 Scopinaro N, Gianetta E, Civalleri D. Two years of clinical experience with biliopancreatic bypass for obesity. Am J Clin Nutr 1980; 33: 506-514.
13. 13 Reginster JY, Denis D, Deroisy R, Albert A, Sarlet N, Collete J. Dual photon absorptiometry of lumbar spine in west European (Belgian) postmenopausal females : normal range and fracture threshhold. Clin Rheumatol 1990; 9: 220-224.
14. 14 Nordin BEC. The definition and diagnosis of osteoporosis [Editorial]. Calcified Tissue Int 1987; 40: 57-58.
15. 15 Cummings SR, Black DM, Nevitt MC, Browner W, Ensurd K. Bone density at various sites for prediction of hip fracture. The study of osteoporotic fractures research group. Lancet 1993; 341: 72-75.
16. 16 McFarlane XA, Bhalla AK, Reeves DE, Morgan LM, Robertson DAF. Osteoporosis: a frequent finding in treated adult coeliac disease. Gut 1995; 36: 710-714.
17. 17 Lindh E, Ljunghall S, Larsson K, Lavo B. Screening for antibodies against gliadin in patients with osteoporosis. J Intern Med 1992; 231: 403-406.
18. 18 Hessov I, Melsen F, Fasth S, Hulten I, Lund B, Sorensen OH. Osteopenia with normal vitamin D metabolites after small bowel resection for Crohn's disease. Scand J Gastroenterol 1984; 19: 691-696.
19. 19 Parfitt AM, Chir B, Miller MJ, Frame B, Villanueva AR, Rao DS, Oliver I, Thomson DL. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978; 89: 193-199.
20. 20 Rickers H, Balslev I, Foltved H, Rodbro P. Bone mineral content before and after intestinal bypass operation in obese patients. Acta Med Scand 1981; 209: 203-207.
21. 21 Parfitt AM., Podenphan J, Villanueva AR, Rao DS, Oliver I, Thomson DL. Metabolic bone disease after intestinal bypass for treatment of obesity. Ann Intern Med 1978; 89: 193-199.
22. 22 Parfitt AM, Foldes J. The ambiguity of intersitial bone thickness: a new approach to the mechanism of trabecular thinning. Bone 1991; 12: 119-122.
23. 23 Frame, B. Metabolic bone disease with and without osteomalacia after intestinal bypass surgery: A bone histomorphometric study. Bone 1985; 6: 211-220.
24. 24 Compston JE, Laker MF, Woodhead JS, Gazet JC, Horton LWL, Ayers AB, Bull HJ, Pilkington TRE. Bone disease after jejunoileal bypass for obesity. Lancet 1978; ii: 1-4.
25. 25 Simmons DJ, Hyland G, Luker PA, Cohen M, Stein T, Wise L. The effects of small-bowel resection or bypass on the rat skeleton. Surgery 1975; 78: 460-471.
26. 26 Fumarola D. Bone disease after jejunoileal bypass. Lancet 1978; 2: 678.
27. 27 Carevale V, Minisola S, Romagnoli E, Marcheggiano A, Iannoni C, Mazzuoli G. Case report: reversal of decreased bone mass by antibiotic treatment in a patient with Whipple's disease. Am J Med Sci 1996; 311 (3): 145-147.
28. 28 Thomas ML, Xu X, Norfleet AM, Watson CS. The presence of functional oestrogen receptors in intestinal epithelial cells. Endocrinology 1993; 132: 426-430.
29. 29. Moreira-Andres MN, Papapietra K, Canizo FJ, Rejas J, Larrodera L, Hawkins FJ. Correlations between bone mineral density, IGF-1 and auxological variables. Eur J Endocrinol 1995; 132: 573-579.
30. 30 Mohan S. IGFBs in bone cell regulation. Growth Regul. 1993; 3: 67-70.
31. 31 Bautista C, Mohan S, Baylink DJ. Insulin-like growth factors 1 and 11 are present in the skeletal tissues of ten vertebrates. Metabolism 1990; 39: 96-100.
32. 32 Brammage R, Mullerman E, Swett E, DeLeon E, Adams S, Bagi CM. Treatment with the rh IGF-I/IGFBP-3 complex increases cortical bone and lean body mass in ovariectomized rats. J Bone Miner Res 1993; 9 (Suppl 1): S71.